Rank | Gene Set | Z-score |
---|---|---|
1 | muscle filament sliding (GO:0030049) | 7.36993822 |
2 | actin-myosin filament sliding (GO:0033275) | 7.36993822 |
3 | skeletal muscle contraction (GO:0003009) | 6.73094840 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.47110292 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.47110292 |
6 | L-phenylalanine catabolic process (GO:0006559) | 6.28984663 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.28984663 |
8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.08922980 |
9 | regulation of skeletal muscle contraction (GO:0014819) | 5.85832735 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 5.83226311 |
11 | actin-mediated cell contraction (GO:0070252) | 5.75018696 |
12 | kynurenine metabolic process (GO:0070189) | 5.66002629 |
13 | creatine metabolic process (GO:0006600) | 5.54259262 |
14 | glyoxylate metabolic process (GO:0046487) | 5.46596609 |
15 | tryptophan catabolic process (GO:0006569) | 5.41656047 |
16 | indole-containing compound catabolic process (GO:0042436) | 5.41656047 |
17 | indolalkylamine catabolic process (GO:0046218) | 5.41656047 |
18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.28222284 |
19 | lysine catabolic process (GO:0006554) | 4.99146912 |
20 | lysine metabolic process (GO:0006553) | 4.99146912 |
21 | cysteine metabolic process (GO:0006534) | 4.97651578 |
22 | striated muscle contraction (GO:0006941) | 4.95160309 |
23 | tryptophan metabolic process (GO:0006568) | 4.93088359 |
24 | bile acid biosynthetic process (GO:0006699) | 4.90660353 |
25 | serine family amino acid catabolic process (GO:0009071) | 4.89738641 |
26 | sulfur amino acid catabolic process (GO:0000098) | 4.87030510 |
27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.82808631 |
28 | glycine metabolic process (GO:0006544) | 4.64691545 |
29 | gluconeogenesis (GO:0006094) | 4.52670058 |
30 | regulation of triglyceride catabolic process (GO:0010896) | 4.49006838 |
31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.41819989 |
32 | 2-oxoglutarate metabolic process (GO:0006103) | 4.40909793 |
33 | sarcomere organization (GO:0045214) | 4.40275190 |
34 | amino-acid betaine metabolic process (GO:0006577) | 4.40129864 |
35 | aromatic amino acid family metabolic process (GO:0009072) | 4.37734231 |
36 | negative regulation of fibrinolysis (GO:0051918) | 4.36774407 |
37 | alpha-amino acid catabolic process (GO:1901606) | 4.36499103 |
38 | serine family amino acid metabolic process (GO:0009069) | 4.34445503 |
39 | coenzyme catabolic process (GO:0009109) | 4.33910569 |
40 | urea metabolic process (GO:0019627) | 4.30267590 |
41 | urea cycle (GO:0000050) | 4.30267590 |
42 | alpha-linolenic acid metabolic process (GO:0036109) | 4.29272173 |
43 | cellular ketone body metabolic process (GO:0046950) | 4.29028374 |
44 | serine family amino acid biosynthetic process (GO:0009070) | 4.25418861 |
45 | skeletal muscle fiber development (GO:0048741) | 4.20623823 |
46 | regulation of fibrinolysis (GO:0051917) | 4.20418812 |
47 | high-density lipoprotein particle remodeling (GO:0034375) | 4.19350152 |
48 | hexose biosynthetic process (GO:0019319) | 4.18487920 |
49 | nitrogen cycle metabolic process (GO:0071941) | 4.17421206 |
50 | cellular amino acid catabolic process (GO:0009063) | 4.11886304 |
51 | response to muscle activity (GO:0014850) | 4.09648769 |
52 | regulation of protein activation cascade (GO:2000257) | 4.09504151 |
53 | actin filament-based movement (GO:0030048) | 4.09292089 |
54 | acetyl-CoA metabolic process (GO:0006084) | 4.07828155 |
55 | cardiac muscle contraction (GO:0060048) | 4.07711615 |
56 | fatty acid beta-oxidation (GO:0006635) | 4.07688045 |
57 | bile acid metabolic process (GO:0008206) | 4.06543130 |
58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.05103343 |
59 | protein carboxylation (GO:0018214) | 4.05103343 |
60 | monosaccharide biosynthetic process (GO:0046364) | 4.04784871 |
61 | short-chain fatty acid metabolic process (GO:0046459) | 4.04150989 |
62 | homocysteine metabolic process (GO:0050667) | 4.03014481 |
63 | aspartate family amino acid catabolic process (GO:0009068) | 4.00958215 |
64 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.97313662 |
65 | proline biosynthetic process (GO:0006561) | 3.95607908 |
66 | complement activation, alternative pathway (GO:0006957) | 3.95154652 |
67 | acylglycerol homeostasis (GO:0055090) | 3.93733146 |
68 | triglyceride homeostasis (GO:0070328) | 3.93733146 |
69 | oxidative phosphorylation (GO:0006119) | 3.93557022 |
70 | branched-chain amino acid catabolic process (GO:0009083) | 3.89906419 |
71 | glucan biosynthetic process (GO:0009250) | 3.88957926 |
72 | glycogen biosynthetic process (GO:0005978) | 3.88957926 |
73 | ethanol oxidation (GO:0006069) | 3.88496360 |
74 | fructose metabolic process (GO:0006000) | 3.86459949 |
75 | protein insertion into membrane (GO:0051205) | 3.86303740 |
76 | fatty acid catabolic process (GO:0009062) | 3.85440891 |
77 | cellular modified amino acid catabolic process (GO:0042219) | 3.83299070 |
78 | regulation of complement activation (GO:0030449) | 3.82956206 |
79 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.81643380 |
80 | fatty acid oxidation (GO:0019395) | 3.80853041 |
81 | regulation of cholesterol esterification (GO:0010872) | 3.80122091 |
82 | carboxylic acid catabolic process (GO:0046395) | 3.78943148 |
83 | organic acid catabolic process (GO:0016054) | 3.78943148 |
84 | glutamate metabolic process (GO:0006536) | 3.78755705 |
85 | negative regulation of cholesterol transport (GO:0032375) | 3.75302779 |
86 | negative regulation of sterol transport (GO:0032372) | 3.75302779 |
87 | protein-lipid complex remodeling (GO:0034368) | 3.72234874 |
88 | macromolecular complex remodeling (GO:0034367) | 3.72234874 |
89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72234874 |
90 | lipid oxidation (GO:0034440) | 3.72173396 |
91 | monocarboxylic acid catabolic process (GO:0072329) | 3.71660466 |
92 | ketone body metabolic process (GO:1902224) | 3.67609682 |
93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67043019 |
94 | myofibril assembly (GO:0030239) | 3.65309105 |
95 | L-serine metabolic process (GO:0006563) | 3.64429934 |
96 | indolalkylamine metabolic process (GO:0006586) | 3.63129316 |
97 | regulation of relaxation of muscle (GO:1901077) | 3.62379475 |
98 | glycogen catabolic process (GO:0005980) | 3.59996995 |
99 | reverse cholesterol transport (GO:0043691) | 3.58927079 |
100 | valine metabolic process (GO:0006573) | 3.58868279 |
101 | branched-chain amino acid metabolic process (GO:0009081) | 3.58233447 |
102 | cellular biogenic amine catabolic process (GO:0042402) | 3.55672948 |
103 | amine catabolic process (GO:0009310) | 3.55672948 |
104 | benzene-containing compound metabolic process (GO:0042537) | 3.55105680 |
105 | biotin metabolic process (GO:0006768) | 3.54852442 |
106 | carnitine metabolic process (GO:0009437) | 3.52571295 |
107 | myotube cell development (GO:0014904) | 3.52242486 |
108 | tyrosine metabolic process (GO:0006570) | 3.50244320 |
109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.49495095 |
110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.49495095 |
111 | plasma lipoprotein particle clearance (GO:0034381) | 3.44563322 |
112 | bile acid and bile salt transport (GO:0015721) | 3.43895252 |
113 | muscle contraction (GO:0006936) | 3.43596069 |
114 | cofactor catabolic process (GO:0051187) | 3.41401602 |
115 | fatty acid transmembrane transport (GO:1902001) | 3.40916411 |
116 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.40870021 |
117 | phospholipid efflux (GO:0033700) | 3.40287825 |
118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.39874295 |
119 | oxaloacetate metabolic process (GO:0006107) | 3.38754613 |
120 | aldehyde catabolic process (GO:0046185) | 3.38745796 |
121 | NAD biosynthetic process (GO:0009435) | 3.36600895 |
122 | skeletal muscle adaptation (GO:0043501) | 3.34326196 |
123 | muscle organ morphogenesis (GO:0048644) | 3.32419150 |
124 | imidazole-containing compound metabolic process (GO:0052803) | 3.30769134 |
125 | NADH metabolic process (GO:0006734) | 3.29289897 |
126 | arginine metabolic process (GO:0006525) | 3.28781359 |
127 | glucan catabolic process (GO:0009251) | 3.27900537 |
128 | tricarboxylic acid cycle (GO:0006099) | 3.27368122 |
129 | flavonoid metabolic process (GO:0009812) | 3.26229023 |
130 | NAD metabolic process (GO:0019674) | 3.25524925 |
131 | carnitine shuttle (GO:0006853) | 3.25330499 |
132 | mitochondrial fusion (GO:0008053) | 3.24180093 |
133 | small molecule catabolic process (GO:0044282) | 3.23397122 |
134 | dicarboxylic acid metabolic process (GO:0043648) | 3.21556423 |
135 | viral transcription (GO:0019083) | 3.19104227 |
136 | regulation of translational fidelity (GO:0006450) | 3.17805062 |
137 | ribosomal small subunit biogenesis (GO:0042274) | 3.17415270 |
138 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.17365463 |
139 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.15515441 |
140 | ubiquinone biosynthetic process (GO:0006744) | 3.13180689 |
141 | motile cilium assembly (GO:0044458) | 3.12542114 |
142 | proline metabolic process (GO:0006560) | 3.11251352 |
143 | muscle cell cellular homeostasis (GO:0046716) | 3.05665877 |
144 | negative regulation of cell size (GO:0045792) | 3.02893882 |
145 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.01786341 |
146 | glycolytic process (GO:0006096) | 2.98661462 |
147 | muscle system process (GO:0003012) | 2.97492546 |
148 | cellular polysaccharide catabolic process (GO:0044247) | 2.96776188 |
149 | respiratory electron transport chain (GO:0022904) | 2.95453640 |
150 | muscle cell fate commitment (GO:0042693) | 2.94581967 |
151 | electron transport chain (GO:0022900) | 2.93107029 |
152 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91420018 |
153 | cardiac myofibril assembly (GO:0055003) | 2.89657300 |
154 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.89602679 |
155 | glucose metabolic process (GO:0006006) | 2.85149889 |
156 | heart process (GO:0003015) | 2.83419198 |
157 | heart contraction (GO:0060047) | 2.83419198 |
158 | translational termination (GO:0006415) | 2.83408898 |
159 | glycogen metabolic process (GO:0005977) | 2.82105723 |
160 | tricarboxylic acid metabolic process (GO:0072350) | 2.81298316 |
161 | translational elongation (GO:0006414) | 2.81257080 |
162 | positive regulation of myotube differentiation (GO:0010831) | 2.80483767 |
163 | actomyosin structure organization (GO:0031032) | 2.80360759 |
164 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.79923281 |
165 | 4-hydroxyproline metabolic process (GO:0019471) | 2.77236672 |
166 | response to inactivity (GO:0014854) | 2.74036683 |
167 | glucan metabolic process (GO:0044042) | 2.73240033 |
168 | cellular glucan metabolic process (GO:0006073) | 2.73240033 |
169 | GDP-mannose metabolic process (GO:0019673) | 2.73189279 |
170 | pentose-phosphate shunt (GO:0006098) | 2.72900348 |
171 | quinone biosynthetic process (GO:1901663) | 2.72406978 |
172 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.71898828 |
173 | positive regulation of synapse maturation (GO:0090129) | 2.71681598 |
174 | carbohydrate biosynthetic process (GO:0016051) | 2.70973623 |
175 | axonemal dynein complex assembly (GO:0070286) | 2.70459575 |
176 | muscle fiber development (GO:0048747) | 2.62370257 |
177 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.61741025 |
178 | polysaccharide catabolic process (GO:0000272) | 2.61251033 |
179 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.61096432 |
180 | ubiquinone metabolic process (GO:0006743) | 2.60633665 |
181 | regulation of actin filament-based movement (GO:1903115) | 2.59129751 |
182 | galactose catabolic process (GO:0019388) | 2.58974262 |
183 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.57917910 |
184 | peptidyl-arginine methylation (GO:0018216) | 2.56401365 |
185 | peptidyl-arginine N-methylation (GO:0035246) | 2.56401365 |
186 | nucleotide salvage (GO:0043173) | 2.56099834 |
187 | muscle tissue morphogenesis (GO:0060415) | 2.53642140 |
188 | skeletal muscle tissue development (GO:0007519) | 2.51601723 |
189 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.47847307 |
190 | regulation of cell communication by electrical coupling (GO:0010649) | 2.46326516 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.48456728 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39008859 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.35889185 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.62587181 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.67583482 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.56590754 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.18497196 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.91509909 |
9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.43299988 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.00551758 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.68419843 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.67244871 |
13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65295936 |
14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60555047 |
15 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.53991313 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.28737408 |
17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.89974942 |
18 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.88322071 |
19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87771644 |
20 | MYC_22102868_ChIP-Seq_BL_Human | 1.83436495 |
21 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.75135535 |
22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73769448 |
23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.72200789 |
24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70996565 |
25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.69167242 |
26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.68137789 |
27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62391189 |
28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.62224430 |
29 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.59335921 |
30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.58335641 |
31 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.57112587 |
32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55792661 |
33 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.55162976 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54362199 |
35 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53785284 |
36 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.51766893 |
37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46870390 |
38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44108521 |
39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.44102611 |
40 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41352326 |
41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40808350 |
42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.40245103 |
43 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39858864 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39443656 |
45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38923148 |
46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37808292 |
47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36714746 |
48 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.35910330 |
49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34834732 |
50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34347083 |
51 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33457956 |
52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33014418 |
53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31868680 |
54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28729594 |
55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28674767 |
56 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.28247819 |
57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26471327 |
58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26211498 |
59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24364451 |
60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19841664 |
61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19318469 |
62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19285597 |
63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18785255 |
64 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.18698426 |
65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17683775 |
66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17294995 |
67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15004949 |
68 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14950645 |
69 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14689441 |
70 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13213364 |
71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11441696 |
72 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11437519 |
73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10496425 |
74 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09632034 |
75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09399611 |
76 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09202584 |
77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08108476 |
78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07977943 |
79 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07777451 |
80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07135978 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06369206 |
82 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06149868 |
83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05814497 |
84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05107742 |
85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04780740 |
86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04693210 |
87 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98936432 |
88 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96825263 |
89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96565705 |
90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96214595 |
91 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92069571 |
92 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.91784728 |
93 | P68_20966046_ChIP-Seq_HELA_Human | 0.91585395 |
94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91269459 |
95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91037397 |
96 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90627172 |
97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90483755 |
98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88534514 |
99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88346034 |
100 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.87688105 |
101 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87048687 |
102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86498855 |
103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86098652 |
104 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.86051684 |
105 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85311775 |
106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85183550 |
107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84953451 |
108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.83252778 |
109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82965291 |
110 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.82786813 |
111 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.82773716 |
112 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82427254 |
113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82307502 |
114 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.81471494 |
115 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.81055464 |
116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.80577281 |
117 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.80217787 |
118 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.77266658 |
119 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.75735211 |
120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74387901 |
121 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74341647 |
122 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.73563670 |
123 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72883395 |
124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72790742 |
125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72779675 |
126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72181914 |
127 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.71033417 |
128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70165684 |
129 | ERA_21632823_ChIP-Seq_H3396_Human | 0.69997692 |
130 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.69938548 |
131 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68839498 |
132 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.68068048 |
133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.66829001 |
134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.66418024 |
135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.66098742 |
136 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65839647 |
137 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64786797 |
138 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.63898785 |
139 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63817171 |
140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.62547644 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.96397589 |
2 | MP0005360_urolithiasis | 6.61976367 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.51746373 |
4 | MP0005365_abnormal_bile_salt | 5.32616815 |
5 | MP0003806_abnormal_nucleotide_metabolis | 4.37114572 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.13572214 |
7 | MP0009840_abnormal_foam_cell | 3.70290882 |
8 | MP0004233_abnormal_muscle_weight | 3.55645679 |
9 | MP0010329_abnormal_lipoprotein_level | 3.04722621 |
10 | MP0005332_abnormal_amino_acid | 2.92650557 |
11 | MP0005083_abnormal_biliary_tract | 2.85163300 |
12 | MP0003646_muscle_fatigue | 2.79626199 |
13 | MP0003252_abnormal_bile_duct | 2.76375290 |
14 | MP0003195_calcinosis | 2.71216347 |
15 | MP0001666_abnormal_nutrient_absorption | 2.55575879 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.54906631 |
17 | MP0006036_abnormal_mitochondrial_physio | 2.32443423 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.29729224 |
19 | MP0005369_muscle_phenotype | 2.24357934 |
20 | MP0000733_abnormal_muscle_development | 2.03079076 |
21 | MP0004019_abnormal_vitamin_homeostasis | 2.00166341 |
22 | MP0002118_abnormal_lipid_homeostasis | 1.96702276 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.93179273 |
24 | MP0003868_abnormal_feces_composition | 1.88024077 |
25 | MP0000609_abnormal_liver_physiology | 1.85507434 |
26 | MP0002822_catalepsy | 1.74550866 |
27 | MP0000013_abnormal_adipose_tissue | 1.72134043 |
28 | MP0000003_abnormal_adipose_tissue | 1.59606449 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56211336 |
30 | MP0004130_abnormal_muscle_cell | 1.54229580 |
31 | MP0005330_cardiomyopathy | 1.53328831 |
32 | MP0003186_abnormal_redox_activity | 1.51043004 |
33 | MP0000751_myopathy | 1.49724725 |
34 | MP0001764_abnormal_homeostasis | 1.48885632 |
35 | MP0006035_abnormal_mitochondrial_morpho | 1.48812458 |
36 | MP0009643_abnormal_urine_homeostasis | 1.46722241 |
37 | MP0005451_abnormal_body_composition | 1.45199319 |
38 | MP0005375_adipose_tissue_phenotype | 1.43428431 |
39 | MP0002138_abnormal_hepatobiliary_system | 1.39478280 |
40 | MP0000749_muscle_degeneration | 1.34703015 |
41 | MP0004270_analgesia | 1.32563034 |
42 | MP0004036_abnormal_muscle_relaxation | 1.31411033 |
43 | MP0001346_abnormal_lacrimal_gland | 1.29139293 |
44 | MP0005058_abnormal_lysosome_morphology | 1.28619983 |
45 | MP0002269_muscular_atrophy | 1.24933831 |
46 | MP0005670_abnormal_white_adipose | 1.22570416 |
47 | MP0003879_abnormal_hair_cell | 1.22086239 |
48 | MP0005623_abnormal_meninges_morphology | 1.21413301 |
49 | MP0004510_myositis | 1.20353508 |
50 | MP0002249_abnormal_larynx_morphology | 1.20301012 |
51 | MP0004084_abnormal_cardiac_muscle | 1.19541915 |
52 | MP0005266_abnormal_metabolism | 1.19291902 |
53 | MP0004215_abnormal_myocardial_fiber | 1.13575949 |
54 | MP0002108_abnormal_muscle_morphology | 1.12933354 |
55 | MP0003011_delayed_dark_adaptation | 1.12443787 |
56 | MP0005084_abnormal_gallbladder_morpholo | 1.12304448 |
57 | MP0000678_abnormal_parathyroid_gland | 1.11029370 |
58 | MP0004858_abnormal_nervous_system | 1.10736442 |
59 | MP0005636_abnormal_mineral_homeostasis | 1.08652894 |
60 | MP0000747_muscle_weakness | 1.08154399 |
61 | MP0005647_abnormal_sex_gland | 1.05675074 |
62 | MP0005409_darkened_coat_color | 1.02350357 |
63 | MP0000598_abnormal_liver_morphology | 1.02063182 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 1.01944300 |
65 | MP0002078_abnormal_glucose_homeostasis | 0.99782958 |
66 | MP0010030_abnormal_orbit_morphology | 0.99480927 |
67 | MP0004484_altered_response_of | 0.95907841 |
68 | MP0005666_abnormal_adipose_tissue | 0.94824613 |
69 | MP0003137_abnormal_impulse_conducting | 0.92707162 |
70 | MP0009642_abnormal_blood_homeostasis | 0.91492884 |
71 | MP0005376_homeostasis/metabolism_phenot | 0.89799101 |
72 | MP0005423_abnormal_somatic_nervous | 0.89444367 |
73 | MP0002971_abnormal_brown_adipose | 0.89147284 |
74 | MP0002132_abnormal_respiratory_system | 0.86777689 |
75 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85152861 |
76 | MP0004087_abnormal_muscle_fiber | 0.84972886 |
77 | MP0008469_abnormal_protein_level | 0.84813776 |
78 | MP0000604_amyloidosis | 0.82494088 |
79 | MP0002332_abnormal_exercise_endurance | 0.81609291 |
80 | MP0009697_abnormal_copulation | 0.80466056 |
81 | MP0000750_abnormal_muscle_regeneration | 0.79031672 |
82 | MP0005535_abnormal_body_temperature | 0.78970232 |
83 | MP0003718_maternal_effect | 0.78838528 |
84 | MP0009763_increased_sensitivity_to | 0.77885788 |
85 | MP0002127_abnormal_cardiovascular_syste | 0.77677760 |
86 | MP0001544_abnormal_cardiovascular_syste | 0.76903137 |
87 | MP0005385_cardiovascular_system_phenoty | 0.76903137 |
88 | MP0001756_abnormal_urination | 0.76126034 |
89 | MP0005076_abnormal_cell_differentiation | 0.73410808 |
90 | MP0003329_amyloid_beta_deposits | 0.71718454 |
91 | MP0001529_abnormal_vocalization | 0.71706500 |
92 | MP0009333_abnormal_splenocyte_physiolog | 0.71692623 |
93 | MP0002972_abnormal_cardiac_muscle | 0.71076487 |
94 | MP0000343_altered_response_to | 0.70455620 |
95 | MP0008260_abnormal_autophagy | 0.70105086 |
96 | MP0005620_abnormal_muscle_contractility | 0.69496931 |
97 | MP0005334_abnormal_fat_pad | 0.69043590 |
98 | MP0005220_abnormal_exocrine_pancreas | 0.68622434 |
99 | MP0002909_abnormal_adrenal_gland | 0.68419093 |
100 | MP0004043_abnormal_pH_regulation | 0.67692195 |
101 | MP0010630_abnormal_cardiac_muscle | 0.67500283 |
102 | MP0005501_abnormal_skin_physiology | 0.66236730 |
103 | MP0000537_abnormal_urethra_morphology | 0.64992068 |
104 | MP0000230_abnormal_systemic_arterial | 0.64949853 |
105 | MP0006138_congestive_heart_failure | 0.64424227 |
106 | MP0008874_decreased_physiological_sensi | 0.63660675 |
107 | MP0010234_abnormal_vibrissa_follicle | 0.63492209 |
108 | MP0009672_abnormal_birth_weight | 0.60505073 |
109 | MP0009278_abnormal_bone_marrow | 0.58675964 |
110 | MP0002106_abnormal_muscle_physiology | 0.57838718 |
111 | MP0003303_peritoneal_inflammation | 0.56298395 |
112 | MP0005448_abnormal_energy_balance | 0.55757620 |
113 | MP0005165_increased_susceptibility_to | 0.55091795 |
114 | MP0008775_abnormal_heart_ventricle | 0.54622376 |
115 | MP0002796_impaired_skin_barrier | 0.53597717 |
116 | MP0001968_abnormal_touch/_nociception | 0.53392895 |
117 | MP0001661_extended_life_span | 0.53392445 |
118 | MP0003953_abnormal_hormone_level | 0.52612051 |
119 | MP0005187_abnormal_penis_morphology | 0.52422916 |
120 | MP0010368_abnormal_lymphatic_system | 0.52316209 |
121 | MP0003705_abnormal_hypodermis_morpholog | 0.52091741 |
122 | MP0002734_abnormal_mechanical_nocicepti | 0.52064195 |
123 | MP0004145_abnormal_muscle_electrophysio | 0.51947330 |
124 | MP0002089_abnormal_postnatal_growth/wei | 0.49470650 |
125 | MP0004085_abnormal_heartbeat | 0.49430267 |
126 | MP0009764_decreased_sensitivity_to | 0.48320343 |
127 | MP0002876_abnormal_thyroid_physiology | 0.47964408 |
128 | MP0009379_abnormal_foot_pigmentation | 0.47511557 |
129 | MP0004185_abnormal_adipocyte_glucose | 0.47415175 |
130 | MP0000681_abnormal_thyroid_gland | 0.47396804 |
131 | MP0000358_abnormal_cell_content/ | 0.46723224 |
132 | MP0000467_abnormal_esophagus_morphology | 0.46463728 |
133 | MP0000759_abnormal_skeletal_muscle | 0.46380805 |
134 | MP0001853_heart_inflammation | 0.44857923 |
135 | MP0002877_abnormal_melanocyte_morpholog | 0.44273430 |
136 | MP0002136_abnormal_kidney_physiology | 0.44235368 |
137 | MP0008873_increased_physiological_sensi | 0.43275770 |
138 | MP0000538_abnormal_urinary_bladder | 0.42910058 |
139 | MP0003453_abnormal_keratinocyte_physiol | 0.42388820 |
140 | MP0001849_ear_inflammation | 0.41862819 |
141 | MP0009765_abnormal_xenobiotic_induced | 0.41431079 |
142 | MP0001765_abnormal_ion_homeostasis | 0.41377146 |
143 | MP0001727_abnormal_embryo_implantation | 0.39981749 |
144 | MP0005452_abnormal_adipose_tissue | 0.39816098 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 7.94354061 |
2 | Nemaline bodies (HP:0003798) | 7.78349701 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.71404446 |
4 | Type 1 muscle fiber predominance (HP:0003803) | 6.02225429 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.89224378 |
6 | Myopathic facies (HP:0002058) | 5.56491912 |
7 | Intrahepatic cholestasis (HP:0001406) | 5.08334789 |
8 | Hyperglycinuria (HP:0003108) | 4.74760833 |
9 | Deep venous thrombosis (HP:0002625) | 4.68541731 |
10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.65700468 |
11 | Xanthomatosis (HP:0000991) | 4.64962849 |
12 | Hyperammonemia (HP:0001987) | 4.55484604 |
13 | Ketosis (HP:0001946) | 4.52862686 |
14 | Hypobetalipoproteinemia (HP:0003563) | 4.51364680 |
15 | Distal lower limb muscle weakness (HP:0009053) | 4.46147779 |
16 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.42427014 |
17 | Abnormality of glycine metabolism (HP:0010895) | 4.38245456 |
18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.38245456 |
19 | Prolonged partial thromboplastin time (HP:0003645) | 4.35019219 |
20 | Hyperglycinemia (HP:0002154) | 4.34588737 |
21 | EMG: myopathic abnormalities (HP:0003458) | 4.28297178 |
22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.17746563 |
23 | Hyperlipoproteinemia (HP:0010980) | 4.13894613 |
24 | Hypoglycemic coma (HP:0001325) | 4.07572126 |
25 | Distal arthrogryposis (HP:0005684) | 3.99659335 |
26 | Cerebral edema (HP:0002181) | 3.91445515 |
27 | Round ear (HP:0100830) | 3.86500002 |
28 | Ketoacidosis (HP:0001993) | 3.85299512 |
29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81612573 |
30 | Calf muscle hypertrophy (HP:0008981) | 3.73084288 |
31 | Muscle fiber splitting (HP:0003555) | 3.71718788 |
32 | Dicarboxylic aciduria (HP:0003215) | 3.71495023 |
33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.71495023 |
34 | Epidermoid cyst (HP:0200040) | 3.66342779 |
35 | Abnormality of the calf musculature (HP:0001430) | 3.55712249 |
36 | Hypolipoproteinemia (HP:0010981) | 3.54460491 |
37 | Hyporeflexia of lower limbs (HP:0002600) | 3.52963208 |
38 | Ulnar deviation of the wrist (HP:0003049) | 3.52722233 |
39 | Progressive muscle weakness (HP:0003323) | 3.51869769 |
40 | Hepatic necrosis (HP:0002605) | 3.49889184 |
41 | Neck muscle weakness (HP:0000467) | 3.48317081 |
42 | Acute encephalopathy (HP:0006846) | 3.47211508 |
43 | Lethargy (HP:0001254) | 3.42321198 |
44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.39883136 |
45 | Increased connective tissue (HP:0009025) | 3.35190611 |
46 | Complement deficiency (HP:0004431) | 3.32379799 |
47 | Muscle stiffness (HP:0003552) | 3.31488213 |
48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30500330 |
49 | Abnormality of serum amino acid levels (HP:0003112) | 3.27711764 |
50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24080630 |
51 | Hypoalphalipoproteinemia (HP:0003233) | 3.21981383 |
52 | Rimmed vacuoles (HP:0003805) | 3.20855410 |
53 | Gout (HP:0001997) | 3.20324275 |
54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.19565894 |
55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.15732657 |
56 | Joint hemorrhage (HP:0005261) | 3.15567125 |
57 | Metabolic acidosis (HP:0001942) | 3.13503073 |
58 | Distal lower limb amyotrophy (HP:0008944) | 3.13074355 |
59 | Asymmetric septal hypertrophy (HP:0001670) | 3.12894287 |
60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.11951829 |
61 | Abnormality of methionine metabolism (HP:0010901) | 3.08062703 |
62 | Myoglobinuria (HP:0002913) | 3.06924528 |
63 | Calcaneovalgus deformity (HP:0001848) | 3.04827771 |
64 | Fetal akinesia sequence (HP:0001989) | 2.99739466 |
65 | Hepatocellular necrosis (HP:0001404) | 2.97533519 |
66 | Bulbar palsy (HP:0001283) | 2.97452336 |
67 | Acute necrotizing encephalopathy (HP:0006965) | 2.96073332 |
68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.95201214 |
69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.86047019 |
70 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84114076 |
71 | Increased muscle lipid content (HP:0009058) | 2.79195940 |
72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.77520789 |
73 | Rhabdomyolysis (HP:0003201) | 2.76008304 |
74 | Achilles tendon contracture (HP:0001771) | 2.71946639 |
75 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.71499630 |
76 | Mitochondrial inheritance (HP:0001427) | 2.70306575 |
77 | Fat malabsorption (HP:0002630) | 2.69780487 |
78 | Lactic acidosis (HP:0003128) | 2.69388053 |
79 | Vomiting (HP:0002013) | 2.69123182 |
80 | Hyperbilirubinemia (HP:0002904) | 2.68008210 |
81 | Increased CSF lactate (HP:0002490) | 2.66693930 |
82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66351270 |
83 | Delayed CNS myelination (HP:0002188) | 2.66090475 |
84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65818512 |
85 | Generalized aminoaciduria (HP:0002909) | 2.64691655 |
86 | Abnormality of purine metabolism (HP:0004352) | 2.62977953 |
87 | Malignant hyperthermia (HP:0002047) | 2.60745247 |
88 | Late onset (HP:0003584) | 2.58720502 |
89 | Subaortic stenosis (HP:0001682) | 2.57946242 |
90 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.57946242 |
91 | Deformed tarsal bones (HP:0008119) | 2.56915878 |
92 | Bundle branch block (HP:0011710) | 2.56893161 |
93 | Abnormality of the Achilles tendon (HP:0005109) | 2.51533931 |
94 | Limb-girdle muscle atrophy (HP:0003797) | 2.51283245 |
95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.51271974 |
96 | Palpitations (HP:0001962) | 2.50336732 |
97 | Exercise-induced myalgia (HP:0003738) | 2.48988215 |
98 | Myotonia (HP:0002486) | 2.46441075 |
99 | Absent phalangeal crease (HP:0006109) | 2.45085858 |
100 | Hypochromic microcytic anemia (HP:0004840) | 2.44290914 |
101 | Nausea (HP:0002018) | 2.41395090 |
102 | Proximal tubulopathy (HP:0000114) | 2.40441598 |
103 | Abnormal atrioventricular conduction (HP:0005150) | 2.36280826 |
104 | Hypercholesterolemia (HP:0003124) | 2.35796613 |
105 | Progressive macrocephaly (HP:0004481) | 2.35282828 |
106 | Ventricular tachycardia (HP:0004756) | 2.35090483 |
107 | Hepatocellular carcinoma (HP:0001402) | 2.32924209 |
108 | Difficulty running (HP:0009046) | 2.32729963 |
109 | Increased purine levels (HP:0004368) | 2.32054630 |
110 | Hyperuricemia (HP:0002149) | 2.32054630 |
111 | Abnormality of complement system (HP:0005339) | 2.31505349 |
112 | Areflexia of lower limbs (HP:0002522) | 2.31435649 |
113 | Conjugated hyperbilirubinemia (HP:0002908) | 2.29824042 |
114 | Ragged-red muscle fibers (HP:0003200) | 2.29102888 |
115 | Skin nodule (HP:0200036) | 2.29029324 |
116 | Heart block (HP:0012722) | 2.27796611 |
117 | Difficulty climbing stairs (HP:0003551) | 2.27532725 |
118 | Generalized muscle weakness (HP:0003324) | 2.26841838 |
119 | EMG: neuropathic changes (HP:0003445) | 2.25938984 |
120 | Frequent falls (HP:0002359) | 2.25591592 |
121 | Glycosuria (HP:0003076) | 2.24692557 |
122 | Abnormality of urine glucose concentration (HP:0011016) | 2.24692557 |
123 | Cholecystitis (HP:0001082) | 2.23347514 |
124 | Abnormal gallbladder physiology (HP:0012438) | 2.23347514 |
125 | Foot dorsiflexor weakness (HP:0009027) | 2.22719682 |
126 | Abnormality of the foot musculature (HP:0001436) | 2.21117518 |
127 | Abnormality of glycolysis (HP:0004366) | 2.18621723 |
128 | Increased serum pyruvate (HP:0003542) | 2.18621723 |
129 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.17928505 |
130 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.17928505 |
131 | Lipid accumulation in hepatocytes (HP:0006561) | 2.15841043 |
132 | Neonatal onset (HP:0003623) | 2.15487673 |
133 | Increased serum lactate (HP:0002151) | 2.14469563 |
134 | Cholelithiasis (HP:0001081) | 2.11189350 |
135 | Abnormality of the neuromuscular junction (HP:0003398) | 2.10732954 |
136 | Fatigable weakness (HP:0003473) | 2.10732954 |
137 | Gowers sign (HP:0003391) | 2.10252695 |
138 | Scapular winging (HP:0003691) | 2.09950365 |
139 | Methylmalonic aciduria (HP:0012120) | 2.09730094 |
140 | Hypoglycemic seizures (HP:0002173) | 2.09667646 |
141 | CNS demyelination (HP:0007305) | 2.08879410 |
142 | Back pain (HP:0003418) | 2.06770792 |
143 | Lower limb amyotrophy (HP:0007210) | 2.06578217 |
144 | Brushfield spots (HP:0001088) | 2.05946074 |
145 | Sudden death (HP:0001699) | 2.05319225 |
146 | Dilated cardiomyopathy (HP:0001644) | 2.05128774 |
147 | Abnormal gallbladder morphology (HP:0012437) | 2.04688391 |
148 | Atrioventricular block (HP:0001678) | 2.02748474 |
149 | Stridor (HP:0010307) | 2.02699367 |
150 | Respiratory failure (HP:0002878) | 2.00941131 |
151 | Weak cry (HP:0001612) | 1.99025709 |
152 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97620185 |
153 | Slender build (HP:0001533) | 1.97560015 |
154 | Spinal rigidity (HP:0003306) | 1.96271027 |
155 | Irritability (HP:0000737) | 1.96266055 |
156 | Malnutrition (HP:0004395) | 1.95153447 |
157 | Easy fatigability (HP:0003388) | 1.95014013 |
158 | Pancreatitis (HP:0001733) | 1.94683670 |
159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92823890 |
160 | Lipoatrophy (HP:0100578) | 1.90270994 |
161 | Steatorrhea (HP:0002570) | 1.90091191 |
162 | Muscle fiber atrophy (HP:0100295) | 1.89821513 |
163 | Exercise intolerance (HP:0003546) | 1.89650394 |
164 | Exercise-induced muscle cramps (HP:0003710) | 1.88931902 |
165 | Popliteal pterygium (HP:0009756) | 1.88639464 |
166 | Abnormality of the calcaneus (HP:0008364) | 1.87055167 |
167 | Generalized amyotrophy (HP:0003700) | 1.86680050 |
168 | Ulnar bowing (HP:0003031) | 1.86000416 |
169 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.84495854 |
170 | Abnormal finger flexion creases (HP:0006143) | 1.84423790 |
171 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.83286867 |
172 | Waddling gait (HP:0002515) | 1.82042886 |
173 | Amniotic constriction ring (HP:0009775) | 1.81803019 |
174 | Abnormality of placental membranes (HP:0011409) | 1.81803019 |
175 | Testicular atrophy (HP:0000029) | 1.76751622 |
176 | Reticulocytosis (HP:0001923) | 1.75473006 |
177 | Diaphragmatic weakness (HP:0009113) | 1.74717916 |
178 | Aplasia of the musculature (HP:0100854) | 1.74051940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.52104226 |
2 | NME2 | 3.70223403 |
3 | TLK1 | 3.63593683 |
4 | ICK | 3.54248009 |
5 | ERN1 | 2.72790457 |
6 | PINK1 | 2.70084639 |
7 | SMG1 | 2.43493149 |
8 | TRIB3 | 2.25063557 |
9 | MAP3K10 | 2.18008510 |
10 | EEF2K | 2.14627934 |
11 | TTN | 2.03859185 |
12 | PDK3 | 2.03342613 |
13 | PDK4 | 2.03342613 |
14 | PKN2 | 2.03074241 |
15 | STK16 | 2.02527145 |
16 | MYLK | 1.95496231 |
17 | MAP3K11 | 1.92855871 |
18 | FGFR4 | 1.92425813 |
19 | GRK6 | 1.91502292 |
20 | KDR | 1.90458755 |
21 | SIK1 | 1.73519341 |
22 | IRAK3 | 1.64496928 |
23 | BUB1 | 1.61664425 |
24 | MUSK | 1.56741645 |
25 | PHKG2 | 1.54139751 |
26 | PHKG1 | 1.54139751 |
27 | PIM2 | 1.51153506 |
28 | TESK1 | 1.48453101 |
29 | PRPF4B | 1.45563752 |
30 | OBSCN | 1.37939650 |
31 | MAP2K3 | 1.22112271 |
32 | NEK1 | 1.21683537 |
33 | MAPK11 | 1.21148926 |
34 | MAP2K6 | 1.19579164 |
35 | EPHA2 | 1.18896849 |
36 | WEE1 | 1.15353194 |
37 | MAP2K2 | 1.14599869 |
38 | MAP2K4 | 1.14372146 |
39 | LATS1 | 1.13991077 |
40 | TESK2 | 1.12157593 |
41 | FLT3 | 1.11624452 |
42 | PIK3CG | 1.10224959 |
43 | CSNK1G3 | 1.09610040 |
44 | LMTK2 | 1.06228305 |
45 | ABL2 | 1.05520325 |
46 | TAOK3 | 1.05485574 |
47 | PRKD3 | 1.03684006 |
48 | MAPK12 | 1.01742487 |
49 | BRAF | 1.01238912 |
50 | TAOK2 | 1.00958418 |
51 | TYK2 | 1.00459801 |
52 | VRK2 | 0.95447959 |
53 | GRK7 | 0.95302602 |
54 | CSNK1G1 | 0.94535280 |
55 | TAOK1 | 0.94035830 |
56 | LIMK1 | 0.91944423 |
57 | MAP3K9 | 0.91341356 |
58 | DAPK3 | 0.90570078 |
59 | NME1 | 0.84237504 |
60 | PDK2 | 0.81920795 |
61 | PBK | 0.81424130 |
62 | ERBB4 | 0.79405346 |
63 | NEK9 | 0.78621639 |
64 | PRKD2 | 0.77905144 |
65 | MAP3K1 | 0.77463644 |
66 | MAPK4 | 0.75089168 |
67 | MAPKAPK3 | 0.73716586 |
68 | WNK4 | 0.73174700 |
69 | CAMK2G | 0.71303639 |
70 | CSNK1A1L | 0.70882392 |
71 | PTK6 | 0.70878578 |
72 | INSRR | 0.69334431 |
73 | TIE1 | 0.68408150 |
74 | ARAF | 0.66674027 |
75 | MAP4K1 | 0.66387892 |
76 | CCNB1 | 0.66243888 |
77 | LRRK2 | 0.65531642 |
78 | ILK | 0.64862032 |
79 | CSNK1G2 | 0.62333648 |
80 | MOS | 0.61002451 |
81 | RIPK1 | 0.59520250 |
82 | MAP3K12 | 0.58728316 |
83 | KSR2 | 0.58016937 |
84 | DAPK2 | 0.58012736 |
85 | CDK4 | 0.57736072 |
86 | DYRK1B | 0.57542026 |
87 | AURKA | 0.55980662 |
88 | MARK1 | 0.54474282 |
89 | CAMK2B | 0.53905792 |
90 | IRAK2 | 0.53814518 |
91 | MTOR | 0.53201862 |
92 | MAP3K13 | 0.52408025 |
93 | IRAK1 | 0.50825681 |
94 | PRKACG | 0.50749328 |
95 | MST1R | 0.50610697 |
96 | MAPK15 | 0.50246443 |
97 | MAP3K3 | 0.46332080 |
98 | PRKAA2 | 0.45861104 |
99 | PRKAA1 | 0.45567046 |
100 | RPS6KA2 | 0.44562364 |
101 | CDK7 | 0.43992772 |
102 | PAK1 | 0.43897575 |
103 | ZAP70 | 0.43439330 |
104 | LATS2 | 0.41916381 |
105 | JAK2 | 0.41578895 |
106 | AKT2 | 0.40573155 |
107 | CDK8 | 0.39775597 |
108 | PDPK1 | 0.39612845 |
109 | CAMK2D | 0.38389871 |
110 | MAP3K5 | 0.37748453 |
111 | CDK19 | 0.35812937 |
112 | RAF1 | 0.34192503 |
113 | PRKACA | 0.33878478 |
114 | CDK11A | 0.33431925 |
115 | PRKCI | 0.32704767 |
116 | RPS6KA5 | 0.32602244 |
117 | SIK2 | 0.32309922 |
118 | STK4 | 0.29828182 |
119 | PAK4 | 0.29783862 |
120 | TBK1 | 0.28495383 |
121 | CDK15 | 0.28381384 |
122 | PRKD1 | 0.28310169 |
123 | DYRK3 | 0.28090699 |
124 | DMPK | 0.27566416 |
125 | RPS6KA1 | 0.26941614 |
126 | BTK | 0.25418735 |
127 | RPS6KB2 | 0.24746842 |
128 | RPS6KL1 | 0.24527908 |
129 | RPS6KC1 | 0.24527908 |
130 | MAPK7 | 0.24405240 |
131 | PDK1 | 0.24279820 |
132 | MAP3K6 | 0.23551242 |
133 | EIF2AK3 | 0.23375461 |
134 | MAP3K8 | 0.22623652 |
135 | DAPK1 | 0.22125967 |
136 | MAP3K7 | 0.21637269 |
137 | PRKG2 | 0.20783023 |
138 | SCYL2 | 0.20587245 |
139 | MAP2K1 | 0.20102178 |
140 | RPS6KA6 | 0.19964002 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73361043 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29286639 |
3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.11937093 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.79854575 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79396959 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.72066323 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.71172458 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69123591 |
9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.64940995 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52217669 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.47689598 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37761877 |
13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.22078605 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20465474 |
15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01827184 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.00036154 |
17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.97774877 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91366921 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89655986 |
20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89199367 |
21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84974702 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84438463 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81961765 |
24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74973736 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72116941 |
26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71108555 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68802480 |
28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.68601461 |
29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.67519164 |
30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60420216 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56972803 |
32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.56578249 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54993606 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53794997 |
35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.52942531 |
36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.45780834 |
37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43555832 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43534502 |
39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43377426 |
40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40745771 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39597459 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37727391 |
43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.36662301 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36617133 |
45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33371277 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24256340 |
47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22883878 |
48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22805505 |
49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21662137 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18590593 |
51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14509113 |
52 | Bile secretion_Homo sapiens_hsa04976 | 1.13290534 |
53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13276019 |
54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07917739 |
55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07579679 |
56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05929614 |
57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98442255 |
58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98125979 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95471715 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93978691 |
61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93634627 |
62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90786476 |
63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90689061 |
64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87690775 |
65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86832461 |
66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85899931 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83477881 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83387775 |
69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78097386 |
70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75858072 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75243712 |
72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72690544 |
73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72004169 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69354538 |
75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68725829 |
76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.67139577 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.64660296 |
78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64475654 |
79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62642087 |
80 | Bladder cancer_Homo sapiens_hsa05219 | 0.62586708 |
81 | Alcoholism_Homo sapiens_hsa05034 | 0.62334812 |
82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59786789 |
83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58952507 |
84 | Ribosome_Homo sapiens_hsa03010 | 0.58413364 |
85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55841229 |
86 | Lysine degradation_Homo sapiens_hsa00310 | 0.55372677 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52419553 |
88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51703148 |
89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43319659 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43164976 |
91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40856973 |
92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40850494 |
93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37952078 |
94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34987655 |
95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33493926 |
96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28819842 |
97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28724247 |
98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27262785 |
99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26755785 |
100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26419838 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24528770 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24176479 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23020204 |
104 | Tight junction_Homo sapiens_hsa04530 | 0.21276453 |
105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21085689 |
106 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.20498141 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20472086 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19426104 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.18887140 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18559293 |
111 | Proteasome_Homo sapiens_hsa03050 | 0.18530836 |
112 | Prion diseases_Homo sapiens_hsa05020 | 0.16907564 |
113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16111272 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15231204 |
115 | Insulin resistance_Homo sapiens_hsa04931 | 0.14939671 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13646080 |
117 | DNA replication_Homo sapiens_hsa03030 | 0.12637305 |
118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.07718855 |
119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06808886 |
120 | Purine metabolism_Homo sapiens_hsa00230 | 0.05449121 |
121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05034109 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04888063 |
123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02414645 |
124 | RNA polymerase_Homo sapiens_hsa03020 | -0.0603360 |
125 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | -0.0588156 |
126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0457449 |
127 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0444339 |
128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0180809 |
129 | Base excision repair_Homo sapiens_hsa03410 | -0.0002737 |